S 3258 — Aviation Medication Transparency Act of 2025

3258 IntroducedReported in Senate (IS)](RS)] <DOC> 119thCalendar CONGRESSNo. 1st Session S.

3258559 To119th requireCONGRESS the2d AdministratorSession ofS. the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes.

3258 [Report No.

119-140] To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes.

Durbin, and Mrs.

Britt)Britt, introducedMr. the following bill;

whichHickenlooper, was read twice and referredMr. to the Committee on Commerce, Science, and Transportation _______________________________________________________________________ A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes.

BeRisch) itintroduced enacted by the Senatefollowing andbill; House of Representatives of the United States of America in Congress assembled, SECTION 1.

which was read twice and referred to the Committee on Commerce, Science, and Transportation September 14, 2026 Reported by Mr.

Cruz, with an amendment [Strike out all after the enacting clause and insert the part printed in italic] _______________________________________________________________________ A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, <DELETED>SECTION 1.

SHORT TITLE.</DELETED> <DELETED> This Act may be cited as the ``Aviation Medication Transparency Act of 2025''.</DELETED> <DELETED>SEC.

2.

AVIATION MEDICATION TRANSPARENCY;

LIST OF APPROVED MEDICATIONS.</DELETED> <DELETED> (a) Purpose.--The purpose of this Act is to ensure that aviation stakeholders, including airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists, who are applicants for medical certification are informed, in a user-friendly and accessible manner, of the medications they may be safely prescribed.</DELETED> <DELETED> (b) In General.--Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration (in this section referred to as the ``Administrator'') shall publish and maintain on a publicly available website of the Federal Aviation Administration (in this section referred to as the ``FAA'') a list of medications that the Administrator, as of the date of publication, has--</DELETED> <DELETED> (1) determined may be safely prescribed to an applicant for medical certification to treat certain medical conditions;

and</DELETED> <DELETED> (2) approved for purposes of the issuance of a medical certification to an airman or air traffic control specialist.</DELETED> <DELETED> (c) Requirements.--To ensure medical appropriateness, user-friendliness, and appropriate dissemination, the list required under subsection (b) shall--</DELETED> <DELETED> (1) be drafted in consultation with--</DELETED> <DELETED> (A) the Aeromedical Innovation and Modernization Working Group (established under section 411(a) of the FAA Reauthorization Act of 2024 (49 U.S.C.

44703 note)) (in this section referred to as the ``Working Group'');</DELETED> <DELETED> (B) institutions of higher education that are accredited by the Aviation Accreditation Board International;</DELETED> <DELETED> (C) the certified exclusive bargaining representatives of air traffic controllers of the FAA certified under section 7111 of title 5, United States Code;</DELETED> <DELETED> (D) organizations representing certified collective bargaining representative of airline pilots;

and</DELETED> <DELETED> (E) any other stakeholder determined relevant by the Working Group;</DELETED> <DELETED> (2) cover all medications approved by the Administrator, including prescription medications and over-the- counter medications;</DELETED> <DELETED> (3) be drafted in a user-friendly and accessible manner and provided to airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists at the time when any such individual first seeks a medical certification;</DELETED> <DELETED> (4) if applicable, indicate the minimum and average period of time an airman or air traffic control specialist is required to have limited or no duties to stabilize on an approved medication;</DELETED> <DELETED> (5) include the list of medications that the Administrator has designated as ``Do Not Issue'';</DELETED> <DELETED> (6) include information for doctors or medical providers to contact the FAA regarding questions related to such list, including through a new or existing mechanism that is accessible to such doctors and medical providers;</DELETED> <DELETED> (7) include any additional information that the Administrator determines is appropriate to provide with respect to what conditions a certain medication may or may not be used to treat, as well as any information to explain why a medication is allowed or prohibited by the FAA;

and</DELETED> <DELETED> (8) include any other information or clarification that the Administrator determines appropriate.</DELETED> <DELETED> (d) Annual Update.--Not later than 1 year after the date of publication of the list required under subsection (b), and annually thereafter, the Administrator shall update such list, as appropriate.</DELETED> SECTION 1.

This Act may be cited as the ``Aviation Medication Transparency Act of 2025''.2026''.

(a) Purpose.--The purpose of this Act is to ensure that aviation stakeholders, including airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists, who are applicants for medical certification or medical clearance, are informed, in a user-friendly and accessible manner, ofof-- (1) the medications theyon maythe be``Do safelyNot prescribed.Issue'' or ``Do Not Fly'' lists;

(b)(2) In General.--Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration (in this section referred to as the ``Administrator'') shall publish and maintain on a publicly available website of the Federal Aviation Administration (in this section referred to as the ``FAA'') a list of medications thatthey the Administrator, as of the date of publication, has-- (1) determined may be safely prescribedpurchase toover-the- ancounter applicantor forbe medicalprescribed; certification to treat certain medical conditions;

and (3) under what conditions the medications described in paragraph (2) approvedmay forbe purposessafely ofused in the issuanceaviation ofenvironment, aconsistent medicalwith certificationthe information provided in the Guide for Aviation Medical Examiners (including any update to ansuch airmanGuide), which is updated monthly, or airsuccessor trafficdocuments controlissued specialist.by the Federal Air Surgeon.

(c)(b) Requirements.--ToIn ensureGeneral.--Not medicallater appropriateness,than user-1 friendliness,year andafter appropriatethe dissemination,date theof listenactment requiredof underthis subsectionAct, (b)the shall--Administrator (1)of bethe draftedFederal inAviation consultationAdministration with--(in (A)this section referred to as the Aeromedical``Administrator'') Innovationshall publish and Modernizationmaintain Workingon Groupa (establishedpublicly underavailable website of the Federal Aviation Administration (in this section 411(a)referred to as the ``FAA'') a list of medications that the FAAAdministrator, Reauthorizationas Actof the date of 2024publication, (49has-- U.S.C.(1) determined may be safely prescribed to or purchased over-the-counter by an applicant for medical certification or medical clearance to treat medical conditions;

and (2) approved for purposes of the issuance of a medical certification or medical clearance to-- (A) an airman who requires a medical certificate or a medical clearance;

or (B) an air traffic control specialist who requires medical clearance.

(c) Requirements.--To ensure information transparency, user- friendliness, and appropriate dissemination, the list required under subsection (b) shall-- (1) incorporate, prior to dissemination, consultation with-- (A) the Aeromedical Innovation and Modernization Working Group (established under section 411(a) of the FAA Reauthorization Act of 2024 (49 U.S.C.

(B) institutionsorganizations ofrepresenting highercollective educationbargaining thatrepresentatives areof accreditedairline bypilots; the Aviation Accreditation Board International;

(D) organizationsinstitutions representingof certifiedhigher collectiveeducation bargainingthat representativeare ofaccredited airlineby pilots;the Aviation Accreditation Board International;

and (E) anyprofessional otherpilot stakeholderflight determinedtraining relevantschools bycertified theunder Workingpart Group;141 of title 14, Code of Federal Regulations;

(2)(F) cover all medications approved by the Administrator,Civil includingAviation prescriptionMedical medicationsAssociation; and over-the-counter medications;

(3)(G) beorganizations draftedrepresenting ingeneral aaviation user-friendlyoperators and accessiblepilots; manner and provided to airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists at the time when any such individual first seeks a medical certification;

(4) if applicable, indicate the minimum and average(H) periodany ofother timestakeholder andetermined airmanrelevant orby airthe trafficAdministrator; control specialist is required to have limited or no duties to stabilize on an approved medication;

(5)(2) includeregarding treatment of medical conditions that may impact the listperformance of duties or the exercise of privileges of an airman certificate, include-- (A) medications thatallowed by the AdministratorAdministrator, hasincluding designatedprescription asmedications ``Doand Notover-the-counter Issue'';medications;

(6)(B) includecontra-indications informationassociated forwith doctors or medical providers to contact the FAAmedications regardingdescribed questionsin relatedsubparagraph to(A); such list, including through a new or existing mechanism that is accessible to such doctors and medical providers;

(7)and include(C) anywhether additionalsuch informationmedications that the Administrator determines is appropriate to provide with respect to what conditions a certain medication may orrequire mayreview not be used to treat, as well as any information to explain why a medication is allowed or prohibited by the FAA;

(3) be drafted in a user-friendly and (8)accessible includemanner anyand, otherin informationaddition to being made publicly available pursuant to subsection (b), made available on MedXPress for airmen, air traffic control specialists, and individuals training to become airmen or clarificationair thattraffic control specialists at the Administratortime determineswhen appropriate.any such individual first seeks a medical certification or medical clearance;

(d)(4) Annualif Update.--Notpracticable, laterindicate thanthe 1minimum yearperiod afterof thetime datean ofairman, publicationair oftraffic thecontrol listspecialist, or individual training to become an airman or air traffic control specialist is required underto subsectionhave (b),limited andor annuallyno thereafter,duties theto Administratorstabilize shallon updatea suchmedication list,allowed asby appropriate.the Administrator;

<all>(5) include the list of medications that the Administrator has designated as ``Do Not Issue'' or ``Do Not Fly'';

(6) include information for doctors or medical providers to contact the FAA regarding questions related to the list published under subsection (b), including through a new or existing mechanism that is accessible to such doctors and medical providers;